2002 Cannabinoids Conditions Treatment 
Project CBD
APRIL 26, 2023
Cannabinoid receptors CB1 and CB2 are the definitive and best-known targets of endogenous and plant-derived cannabinoids, but they’re far from the only ones. The first evidence of an endocannabinoid interacting with PPARs came in 2002, when a research team in Tennessee showed that a metabolite of 2-AG activated PPAR- a.
Greencamp
AUGUST 25, 2018
Hence, lupus patients often look for complementary treatments for controlling their symptoms. Fortunately enough, a large body of evidence shows that cannabis may prove to be a good treatment option for lupus. I wanted to see just how good cannabis might be for this condition, and so I decided to go over the available research.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
The Cannigma
JANUARY 3, 2023
You’ll want a specific combination of cannabinoids and terpenes, and what works for one person may not work for the next. Dr. Ethan Russo, a renowned cannabis scientist, published a paper in 2002 detailing historical uses of cannabis in women’s health. But it’s not enough to smoke a joint and expect the cramps to disappear.
Alchimia
JUNE 20, 2016
CBD is a cannabinoid present in cannabis plants with a very similar molecular structure to THC but without any kind of psychoactive effect. It has been demonstrated that CBD has low affinity with the CB1 and CB2 cannabinoid receptors , but it does act on other receptors of the human body like GPR55 or 5-HT1A. What is CBD?
Green Relief
FEBRUARY 20, 2018
Over the years of helping clients optimize their health through nutrigenomics, I’ve seen some amazing results including successful weaning off harmful pharmaceuticals, and reversals of difficult to treat conditions (ie: cancer, autoimmune). Immune system pathways (for targeted cannabinoid therapy) 12. Piomeli, Daniele (2002).
Green Relief
FEBRUARY 19, 2018
Over the years of helping clients optimize their health through nutrigenomics, I’ve seen some amazing results including successful weaning off harmful pharmaceuticals, and reversals of difficult to treat conditions (ie: cancer, autoimmune). Immune system pathways (for targeted cannabinoid therapy) 12. Piomeli, Daniele (2002).
LifeCannMD
OCTOBER 30, 2020
Cannabis Terpenes are not only the cause of the plant’s fragrance and color, but they also work with cannabinoids to elicit specific types of effects to be used in treatment. If a patient isn’t choosing their Medical Marijuana by the Terpenes they include, they might not be getting the optimum effect to treat their condition.
Expert insights. Personalized for you.
289 
Let's personalize your content